R&D

Genstar-backed Signant Health Acquires Ametris: Implications for eCOA and Digital Outcome Measures

6 min

FDA Concerns About Cancer Risk Sink Fulcrum Therapeutics’ Sickle Cell Disease Drug: Implications for SCD Pipeline and BD Strategy

FDA · sickle cell disease · 4 min

Biotech's Strategic Turning Point: Insights from Jeremy Levin

FDA · 5 min

Bio-IT World Conference 2026: Live Event Coverage

FDA · 5 min

Kenya Court Halts U.S. Ebola Quarantine Facility Plans: Pharma Sector Analysis

FDA · Ebola · 6 min

Diversity in Medical Education: Bridging the Gap to a Representative Healthcare Workforce

FDA · 5 min

Biotech's Future: Insights from Jeremy Levin

FDA · 8 min

Trump's Disloyalty Claims: Implications for Louisiana's Republican Primary

FDA · 6 min

CG Life Appoints Collette Douaihy Chief Creative Officer to Drive Biopharma Marketing Innovation

FDA · 9 min

OpenEvidence's Approach to Hospitals: A New Era in Pharma

FDA · 9 min

Allogene CEO David Chang Steps Down: Implications for the Biotech Sector

FDA · cell therapy · 8 min

Design Therapeutics' Friedreich's Ataxia Data and Vincentage's Obesity Results: A Strategic Analysis

FDA · obesity · 7 min